封面
市場調查報告書
商品編碼
2019090

乳酸計市場機會、成長要素、產業趨勢分析及2026-2035年預測。

Lactate Meters Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: | 出版商: Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球乳酸儀市場預計到 2025 年將價值 1.709 億美元,年複合成長率為 9.1%,到 2035 年將達到 4.039 億美元。

乳酸檢測儀市場-IMG1

受慢性疾病和嚴重健康問題發病率上升以及人們對運動表現監測日益成長的需求推動,乳酸儀行業正在穩步擴張。乳酸測量在臨床和以運動表現為導向的環境中都變得越來越重要,因為它能夠提供有關體內代謝活動和氧氣利用情況的重要資訊。久坐不動的生活方式和不良飲食習慣引發的健康問題日益嚴重,導致慢性疾病的增加,進一步加劇了對先進診斷工具的需求。技術進步,特別是穿戴式監測解決方案的進步,正在透過連續、即時的數據傳輸和更高的便利性,改變乳酸水平的追蹤方式。這些創新提升了使用者體驗,並正在醫療、運動和健身領域中得到更廣泛的應用。動態監測代謝變化的能力在改善患者管理和最佳化運動表現方面發揮著至關重要的作用,這使得乳酸儀成為現代診斷和監測實踐中不可或缺的工具。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 1.709億美元
預測金額 4.039億美元
複合年成長率 9.1%

乳酸儀是一種專門用於測量血液和其他生物檢體中乳酸濃度的儀器,有助於評估代謝活動和組織氧合。這些儀器在識別和管理各種疾病方面發揮著至關重要的作用,同時也支持非臨床環境下的性能分析。最新解決方案提供的連續監測功能提高了測量精度,並有助於及時做出決策。

到2025年,電池供電型設備將佔據80.7%的市場。這些設備因其便攜性、緊湊設計和易用性而廣受歡迎,適用於包括就地檢驗和現場環境在內的各種應用場景。它們無需複雜的基礎設施即可提供快速可靠的檢測結果,這正是推動其廣泛應用的關鍵因素。

預計到2025年,重症監護監測市場規模將達到5,990萬美元,並在2035年之前以9.4%的複合年成長率成長。該市場的成長主要歸功於重症監護環境中乳酸檢測的日益普及,用於評估代謝狀態和支持病患監測。此外,對快速診斷解決方案和改善臨床療效的需求不斷成長,也推動了該市場的擴張。

美國乳酸儀市場預計到2025年將達到6,510萬美元,並在2026年至2035年間以8.3%的複合年成長率成長。強大的分銷網路、主要製造商的佈局以及人們對先進監測解決方案日益成長的認知,都推動了市場擴張。此外,人們對健身和運動表現追蹤的日益關注,也促進了對攜帶式和穿戴式乳酸監測設備的需求成長。

目錄

第1章:調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性協議
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 慢性病和嚴重盛行率增加
      • 穿戴式科技的進步
      • 人們對運動表現監測的興趣日益濃厚
    • 產業潛在風險與挑戰
      • 對乳酸監測的認知不足
    • 市場機遇
      • 拓展至臨床及照護現場診斷領域
  • 成長潛力分析
  • 監理情勢
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢
  • 專利分析
  • 價格分析(2025 年)(基於初步調查)
  • 客戶洞察(基於初步研究)
  • 人工智慧和生成式人工智慧對市場的影響
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
    • LAMEA
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品類型發布
    • 業務拓展計劃

第5章 市場估算與預測:依產品類型分類,2022-2035年

  • 電池式乳酸計
  • 可充電乳酸計

第6章 市場估計與預測:依應用領域分類,2022-2035年

  • 運動醫學和健身監測
  • 重症監護監測
  • 其他用途

第7章 市場估計與預測:依最終用途分類,2022-2035年

  • 運動健身中心
  • 醫院和診所
  • 居家醫療環境
  • 其他最終用戶

第8章 市場估計與預測:依地區分類,2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章:公司簡介

  • Abbott
  • arkray
  • B-ARM
  • COSMED
  • EFK
  • nova biomedical
  • pkvitality
  • SENSA CORE
  • TECOM
  • VivaChek
簡介目錄
Product Code: 12948

The Global Lactate Meters Market was valued at USD 170.9 million in 2025 and is estimated to grow at a CAGR of 9.1% to reach USD 403.9 million by 2035.

Lactate Meters Market - IMG1

The lactate meters industry is expanding steadily, driven by the increasing incidence of chronic and critical health conditions along with a growing emphasis on monitoring athletic performance. Lactate measurement has become increasingly important in both clinical and performance-focused environments, as it provides valuable insights into metabolic activity and oxygen utilization within the body. Rising health concerns linked to sedentary lifestyles and poor dietary habits are contributing to higher rates of chronic diseases, further strengthening demand for advanced diagnostic tools. Technological advancements, particularly in wearable monitoring solutions, are transforming how lactate levels are tracked by offering continuous, real-time data and improved convenience. These innovations are enhancing user experience and expanding adoption across healthcare, sports, and fitness sectors. The ability to monitor metabolic changes dynamically plays a crucial role in improving patient management and performance optimization, positioning lactate meters as an essential component in modern diagnostic and monitoring practices.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$170.9 Million
Forecast Value$403.9 Million
CAGR9.1%

Lactate meters are specialized devices designed to measure lactate concentrations in blood or other biological samples, helping assess metabolic activity and tissue oxygenation. These devices play a critical role in identifying and managing various medical conditions while also supporting performance analysis in non-clinical environments. Continuous monitoring capabilities provided by modern solutions are improving accuracy and enabling timely decision-making.

The battery-operated segment held an 80.7% share in 2025. These devices are widely preferred due to their portability, compact design, and ease of use across various applications, including point-of-care testing and field-based environments. Their ability to deliver quick and reliable results without requiring complex infrastructure supports widespread adoption.

The critical care monitoring segment is valued at USD 59.9 million in 2025 and is expected to grow at a CAGR of 9.4% through 2035. Growth in this segment is driven by the increasing use of lactate testing in intensive care settings to evaluate metabolic conditions and support patient monitoring. The rising demand for rapid diagnostic solutions and improved clinical outcomes is further contributing to segment expansion.

U.S. Lactate Meters Market captured USD 65.1 million in 2025 and is expected to grow at a CAGR of 8.3% from 2026 to 2035. Strong distribution networks, the presence of leading manufacturers, and increasing awareness of advanced monitoring solutions are supporting market expansion. Additionally, growing interest in fitness and performance tracking is contributing to increased demand for portable and wearable lactate monitoring devices.

Key companies operating in the Global Lactate Meters Market include Abbott, Arkray, Nova Biomedical, COSMED, EFK, SENSA CORE, TECOM, B-ARM, PKVitality, and VivaChek. Companies in the Global Lactate Meters Market are strengthening their position through innovation and strategic expansion. They are investing in advanced technologies to develop more accurate, portable, and user-friendly devices. Firms are focusing on integrating wearable solutions and real-time monitoring capabilities to enhance usability across healthcare and fitness applications. Strategic collaborations and partnerships are enabling broader distribution and improved product accessibility. Companies are also expanding their presence in emerging markets while enhancing production capabilities to meet growing demand. Additionally, continuous improvements in product design, functionality, and data integration are helping companies maintain competitiveness and address evolving consumer and clinical requirements.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product type trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic and critical conditions
      • 3.2.1.2 Advancements in wearable technology
      • 3.2.1.3 Increased focus on athletic performance monitoring
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Lack of awareness about lactate monitoring
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion into clinical and point-of-care diagnostics
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Patent analysis
  • 3.8 Pricing analysis, 2025 (Driven by primary research)
  • 3.9 Customer insights (Driven by primary research)
  • 3.10 Impact of AI and generative AI on the market
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Battery operated lactate meters
  • 5.3 Chargeable lactate meters

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Sports medicine and fitness monitoring
  • 6.3 Critical care monitoring
  • 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Sports and fitness centers
  • 7.3 Hospitals and clinics
  • 7.4 Homecare settings
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 arkray
  • 9.3 B-ARM
  • 9.4 COSMED
  • 9.5 EFK
  • 9.6 nova biomedical
  • 9.7 pkvitality
  • 9.8 SENSA CORE
  • 9.9 TECOM
  • 9.10 VivaChek